Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa is a chronic skin condition causing painful lumps and scarring, often triggered by smoking and obesity, and requires varying treatments based on severity.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Future acne treatments should aggressively target inflammation to prevent scarring.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Overexpressing follistatin in mice delays wound healing and reduces scar size.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Effective treatments for severe alopecia areata are still lacking.